Kymera Therapeutics (KYMR) Ukubelenga kwa Stock
Ipimo lya nomba $112.02Yasungwa 25 Sep 2026 19:59 UTC
Ukubula -3.27%
Cipimo ca AI : KYMR
AI ileposa chilango ca nshita ya kucila ku bushiku bumo bwa kucita malishiti, ku mpela ya mulungu na ku mpela ya mweshi. Ukukula kulapimwa ukutula ku nshita ya kucila. Aya ni makani ya statistics, te malangililo ya kubika ndalama.
Ipimo mu nshiku 6 ishacita
Premium ilasanga ifyo AI ilatasha ukucita pa 1 day, 1 week na 1 month pa stock iyi na pa stock shonse shimbi.
Fungula Premium🔒 Ukukwata kwa ifipimo
Umulandu wa forecast — bonse ba kale pamo na nshita ya kucila — ni cipande ca Premium.
Fungula PremiumPa Kampani Ici
Kymera Therapeutics, Inc. operates as a biopharmaceutical company focused on discovering and developing novel small-molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s natural protein degradation machinery. Kymera Therapeutics serves customers in Massachusetts.
